In October, Eli Lillys Zepbound and Mounjaro were removed from the drug shortage list after nearly two years, though the FDA warned that there still may be intermittent localized supply disruptions. The removal from the listwhich bars outsourcing facilities from producing compounded versionsspurred the Outsourcing Facilities Association to file a lawsuit against the FDA, saying the move will deprive much of the public of access to a needed medicine. In response, the FDA agreed to reevaluate the situation and will allow compounding to continue during this period
"Canadian Patent Database / Base de donnes sur les brevets canadiens"
Switch from 3 large meals to 5-6 small meals spaced every 3 hours
Journal of Clinical Medicine, 13 (21), 6336
Retatrutide is still investigational, and ongoing Phase 3 studies and long-term follow-up will clarify its complete safety profile
And for a few conditions, the only evidence is a single study in rats